Shijun Hong

Shijun Hong


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2020 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
PDF file
CMC-L Ma
C-L Ma
LLL Li
L Li
GYG-M Yang
G-M Yang
ZZZ-B Zhang
Z-B Zhang
YZY-N Zhao
Y-N Zhao
SHShijun Hong
Shijun Hong
Methamphetamine (MA) abuse induces neurotoxicity and causes neuronal cell apoptosis. Gastrodin is a traditional Chinese herbal medicine used for the treatment of nerve injuries, spinal cord injuries, and some central nervous system diseases as well. The present study investigated the neuroprotective effects of gastrodin against MA-induced neurotoxicity in neuronal cells and its potential protective mechanism. The primary cortex neuronal culture was divided into four groups (control group, MA group, MA + gastrodin group, and MA + gastrodin + small interfering RNA group). The neurotoxicity of MA was assessed by detecting apoptotic cells by terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling assay and cell viability by cell counting kit 8 (CCK-8) method, the Tuj1-positive cells and the average axonal length were detected by immunofluorescence, and the expressions of cyclic adenosine monophosphate (cAMP), protein kinase A (PKA), cAMP-response element-binding (CREB), and brain-derived neurotrophic factor (BDNF) proteins were detected by Western blot. The results of CCK-8 assay showed that 0.5 mM MA was an optimal concentration that induced neurotoxicity (p < 0.01). Pretreatment with 25 mg/L gastrodin exerted maximum protective effects on neuronal cells. The expression levels of cAMP, PKA, phosphorylated PKA, CREB, phosphorylated CREB, and BDNF proteins were decreased in the MA group, and pretreatment with gastrodin upregulated the expression levels of these proteins (p < 0.01). The expressions of PKA and CREB proteins showed no significant changes in the control group, MA group, and gastrodin group. Compared the MA + gastrodin + small interfering RNA group with MA + gastrodin group, the Tuj1-positive cells and the average axonal length were decreased significantly, while the number of apoptotic cells was increased (p < 0.05). Gastrodin has neuroprotective effects against MA-induced neurotoxicity, which exerts neuroprotective effects via regulation of cAMP/PKA/CREB signaling pathway and upregulates the expression of BDNF.

24 September 2022 in Neuropharmacology
Verified
Journal Article
Closed access
GYGenmeng Yang
Genmeng Yang
JLJuan Li
Juan Li
CLChi-Kwan Leung
Chi-Kwan Leung
BSBaoyu Shen
Baoyu Shen
CWChan Wang
Chan Wang
LLLihua Li
Lihua Li

8 January 2022 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
BSBaoyu Shen
Baoyu Shen
DZDongxian Zhang
Dongxian Zhang
XZXiaofeng Zeng
Xiaofeng Zeng
LGLina Guan
Lina Guan
GYGenmeng Yang
Genmeng Yang
LLLihua Li
Lihua Li

9 August 2023 in Toxicology Letters
Verified
Journal Article
Closed access
WDWenjuan Dong
Wenjuan Dong
JWJia Wan
Jia Wan
HYHao Yu
Hao Yu
BSBaoyu Shen
Baoyu Shen
GYGenmeng Yang
Genmeng Yang
SHShijun Hong
Shijun Hong

6 September 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
BSBaoyu Shen
Baoyu Shen
RZRuilin Zhang
Ruilin Zhang
GYGenmeng Yang
Genmeng Yang
YPYanxia Peng
Yanxia Peng
QNQianyun Nie
Qianyun Nie
LLLihua Li
Lihua Li
In the past decade, methamphetamine (METH) abuse has sharply increased in the United States, East Asia, and Southeast Asia. METH abuse not only leads to serious drug dependence, but also produces irreversible neurotoxicity. Currently, there are no approved pharmacotherapies for the treatment of METH use disorders. Cannabidiol (CBD), a major non-psychoactive (and non-addictive) cannabinoid from the cannabis plant, shows neuroprotective, antioxidative, and anti-inflammatory properties under METH exposure. At present, however, the mechanisms underlying these properties remain unclear, which continues to hinder research on its therapeutic potential. In the current study, computational simulations showed that CBD and METH may directly bind to the dopamine receptor D1 (DRD1) via two overlapping binding sites. Moreover, CBD may compete with METH for the PHE-313 binding site. We also found that METH robustly induced apoptosis with activation of the caspase-8/caspase-3 cascade in-vitro and in-vivo, while CBD pretreatment prevented these changes. Furthermore, METH increased the expression of DRD1, phosphorylation of Methyl-CpG-binding protein 2 (MeCP2) at serine 421 (Ser421), and level of intracellular Ca2+in-vitro and in-vivo, but these effects were blocked by CBD pretreatment. The DRD1 antagonist SCH23390 significantly prevented METH-induced apoptosis, MeCP2 phosphorylation, and Ca2+ overload in-vitro. In contrast, the DRD1 agonist SKF81297 markedly increased apoptosis, MeCP2 phosphorylation, and Ca2+ overload, which were blocked by CBD pretreatment in-vitro. These results indicate that CBD prevents METH-induced neurotoxicity by modulating DRD1-mediated phosphorylation of MeCP2 and Ca2+ signaling. This study suggests that CBD pretreatment may resist the effects of METH on DRD1 by competitive binding.

4 January 2020 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
GYGen-Meng Yang
Gen-Meng Yang
LLLu Li
Lu Li
FXFeng-Lin Xue
Feng-Lin Xue
CMChen-Li Ma
Chen-Li Ma
XZXiaofeng Zeng
Xiaofeng Zeng
LLLi-Hua Li
Li-Hua Li